We read a recent opinion article titled, “An opaque model of drug approval”, in The Telegraph with interest. We respectfully disagree with the author, and appreciate the opportun...

Zydus Cadila on Thursday said it has received approval from the Drug Controller General of India (DCGI) for its new drug application for Saroglitazar to treat a particular condition of liver, known as...

Amid rising coronavirus cases in India, for the first time a combination of two drugs, which is widely used for controlling HIV infection, was administered on an elderly Italian couple undergoing trea...

Haste makes waste. This adage can serve as a timely warning for the Drug Controller General of India which has notified the final rules — a draft version was issued last year — to guide clinical t...

The central drug regulator has given its go-ahead to a proposal by the Indian Council of Medical Research for the clinical trial of convalescent plasma in COVID-19 patients, as per the protocol develo...